PWR Holdings' North American arm, C&R Racing Inc., has landed a $8.9 million AUD order to supply advanced cooling systems for a US government aerospace project, marking a pivotal milestone in its defence sector expansion.
Immuron has submitted its Phase 2 clinical study report for Travelan® to the FDA, revealing statistically significant immunological and microbiome benefits. The company is preparing to engage the FDA for Phase 3 trial discussions while progressing a large field study with military personnel.
